Choline Supplementation Shows Long-Term Developmental Benefits for Children with Fetal Alcohol Spectrum Disorder

A new study demonstrates that children affected by prenatal alcohol exposure (PAE) experience significant long-lasting cognitive gains following treatment with supplemental choline, an essential nutrient. Fetal alcohol spectrum disorder (FASD), which affects 1–5% of the global population, encompasses multiple diagnoses involving physical, cognitive, and behavioral challenges that currently have limited treatment options. This research indicates that choline supplementation represents a potentially scalable and accessible intervention for the neurodevelopmental differences associated with FASD. The findings offer hope to affected children and families seeking effective therapeutic approaches to mitigate the impact of prenatal alcohol exposure.